Christopher Tiessen

Christopher Tiessen

Auto-generated profile, based on publicly available information

Christopher Tiessen

University of Calgary

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2026 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
CTChristopher Tiessen
Christopher Tiessen
TLTimothy Leonard
Timothy Leonard
Walter HerzogWalter Herzog
Walter Herzog
Titin’s proximal immunoglobulin domains have been shown to unfold and refold at physiological forces in isolated protein constructs. In this study, we use mechanical testing of intact isolated rabbit psoas myofibrils coupled with mathematical modeling to confirm that immunoglobulin domain unfolding and refolding does indeed occur at physiological forces in situ. We show that immunoglobulin domains refold at physiological forces, when titin is situated in its physiological configuration in an intact sarcomere.

1 August 2026 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
FSFaizan Syed
Faizan Syed
LOLatif Omerkhil
Latif Omerkhil
JHJason J. Howard
Jason J. Howard
CTChristopher Tiessen
Christopher Tiessen
SVSunnie Vuong
Sunnie Vuong
Walter HerzogWalter Herzog
Walter Herzog
To our knowledge, this is the first study to show that two hip adductor muscles from the same children with spastic cerebral palsy differ in single muscle fiber force production and thin-filament protein content. These findings suggest that cellular muscle properties in cerebral palsy can vary substantially between muscles within the same child, even among muscles commonly treated as one functional group.

8 September 2026 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PVPamela Veale
Pamela Veale
CTChristopher Tiessen
Christopher Tiessen
VGVithya Gnanakumar
Vithya Gnanakumar
We report a 9‐year‐old female with FOXP1 syndrome due to a de novo in‐frame deletion in the FOXP1 gene. The child has a severe neurodevelopmental disorder including global developmental delay and autism spectrum disorder. At age 2, she developed severe headbanging, which was progressive and did not respond to multidisciplinary, behavioral management strategies or to multiple medication treatments. Although repetitive behaviors are frequent in patients with FOXP1 variants, severe and intractable headbanging has not been reported to date. Levodopa/carbidopa was prescribed at age 7 due to progressive foot dystonia and contracture development. This treatment was not clearly beneficial for the dystonia and foot position, but immediate improvement in headbanging was observed and the response sustained for over 19 months. The FOXP1 gene codes for a transcriptional regulator protein that has been shown to regulate the development of brain and spinal motor neurons, and some evidence has linked FOXP1 to the differentiation of midbrain dopaminergic neurons via the homeobox protein PITX3, thus providing a potential mechanism for the observed benefit. This case report may provide expansion of the behavioral phenotype associated with FOXP1 variants and suggests avenues for further animal research and/or clinical trial of levodopa in individuals with FOXP1 variants.

6 October 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
CTChristopher Tiessen
Christopher Tiessen
ASArmaan Sekhon
Armaan Sekhon
DDDhairya Desai
Dhairya Desai
TLTim Leonard
Tim Leonard
FSFatima Abu Shagra
Fatima Abu Shagra
Walter HerzogWalter Herzog
Walter Herzog
Residual force enhancement (RFE) is an inherent property of mammalian skeletal muscle. After eccentric stretch, muscle produces increased steady-state force compared to purely isometric contraction at the same sarcomere length and activation level. This property has been known for over 70 y and yet remains largely unexplained. Titin, a giant spring-like protein responsible for passive force generation and stabilization of the sarcomere, has been suggested as a potential candidate for causing RFE. To test whether titin may be responsible for RFE, we used multiple titin immunolabels on single isolated myofibrils to approximately track the migration of individual titin segments in real-time. In comparison to many previous attempts to label titin in sarcomeres, our labeling using N2A and distal PEVK labels did not impact mechanical properties of the myofibril and thus permitted accurate tracking of titin segments within single sarcomeres. We found the approximate length of titin’s PEVK segment was significantly longer in RFE compared to isometric control activations at similar final sarcomere lengths, indicating increased force on titin filaments in RFE. Using a modified worm-like chain model, we predict titin-associated force contributes up to 62% of increased force during RFE. Additionally, using a continuous eccentric stretch protocol, we provide indirect evidence suggesting titin–actin interactions may be responsible for increased force on titin during RFE. To date, this represents one of the most convincing pieces of evidence suggesting that titin is responsible for RFE. Thus, our data indirectly support the proposed “three-filament model” where muscle activation induces cross-bridge interactions and titin–actin interactions.

17 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMatheus Batista Carneiro
Matheus Batista Carneiro
SSSantiago Aguiar E. Soares
Santiago Aguiar E. Soares
CTChris Tiessen
Chris Tiessen
CGCamila Gaio
Camila Gaio
BPBen Perks
Ben Perks
NPNathan C Peters
Nathan C Peters
Protective immunity against many infectious diseases develops following primary infection, called infection induced immunity (III), and provides a blueprint for vaccination. However, many vaccination strategies have failed. In the parasitic Leishmania major model of self-healing cutaneous disease, control of secondary challenge infection relies on pre-existing T helper (Th)1-dependent activation of skin-infiltrating monocytes for elimination of intracellular parasites. To better understand immune-evasion of pre-existing Th1 immunity by pathogens, we investigated the pathogen-niche established following non-healing challenge infection with the L. amazonensis parasite in a setting of pre-existing III. Following secondary challenge, pre-existing Th1 III initially controlled infection but ultimately failed. Loss of protection was not overtly STAT6- or IL-10-mediated. Rather, monocyte-lineage tracing revealed inflammatory monocyte-derived PD-L1+PD-L2+ macrophages provide an intracellular pathogen-niche and facilitate evasion of pre-existing Th1 immunity. Anti-PD-1 immune checkpoint blockade enhanced uninfected, but not infected, monocyte-derived cell activation and depletion of monocyte-derived precursors improved parasite control. These observations suggest that evasion of pre-existing Th1 immunity in this setting is not due to a failure of the Th1 response, but rather due to infected-cell intrinsic defects in activation.